Medicenna Therapeutics Corp. Adjustments For Decrease Increase In Other Operating Receivables
Medicenna Therapeutics Corp. (MDNAF) reported Adjustments For Decrease Increase In Other Operating Receivables of CAD 1.23 million for the 3-month period ending 2023-03-31, per its 20-F filed 2023-06-27.
Discontinued › Notes › Receivables
ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables · last filed 2023-06-27
- Medicenna Therapeutics Corp. adjustments for decrease increase in other operating receivables for the quarter ending 2023-03-31 was 1.23M CAD.
- Medicenna Therapeutics Corp. adjustments for decrease increase in other operating receivables for the quarter ending 2022-03-31 was -392.00K CAD.
- Medicenna Therapeutics Corp. adjustments for decrease increase in other operating receivables for the quarter ending 2021-03-31 was -1.61M CAD.
| Period end | Adjustments For Decrease Increase In Other Operating Receivables 3 month | Adjustments For Decrease Increase In Other Operating Receivables 12 month |
|---|---|---|
| 2023-03-31 | 1.23M CAD 20-F · filed 2023-06-27 | |
| 2022-03-31 | -392.00K CAD 20-F · filed 2023-06-27 | -392.00K CAD 20-F · filed 2022-06-22 |
| 2021-03-31 | -1.61M CAD 20-F · filed 2023-06-27 | -1.61M CAD 20-F · filed 2022-06-22 |
| 2020-03-31 | 139.00K CAD 20-F · filed 2022-06-22 |